NABRIVA THERAPEUTICS AG's ticker is NBRVXXXX and the CUSIP is 62957M104. A total of 4 filers reported holding NABRIVA THERAPEUTICS AG in Q2 2017. The put-call ratio across all filers is - and the average weighting 3.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $139,000 | – | 11,593 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 3,151,700 | $23,638,000 | 6.46% |
| Omega Fund Management, LLC | 1,145,890 | $8,594,000 | 6.38% |
| ACUTA CAPITAL PARTNERS, LLC | 558,771 | $4,191,000 | 2.01% |
| EcoR1 Capital, LLC | 562,741 | $4,221,000 | 1.66% |
| Opaleye Management Inc. | 270,000 | $2,025,000 | 1.35% |
| Boxer Capital, LLC | 176,710 | $1,325,000 | 1.18% |
| Novo Holdings A/S | 1,054,823 | $7,911,000 | 0.83% |
| FT Options LLC | 49,555 | $372,000 | 0.32% |
| JACKSON PARK CAPITAL, LLC | 26,000 | $195,000 | 0.27% |
| Rock Springs Capital Management LP | 426,000 | $3,195,000 | 0.24% |